Literature DB >> 18787086

Eccentric contractions do not induce rhabdomyolysis in malignant hyperthermia susceptible mice.

Benjamin T Corona1, Clement Rouviere, Susan L Hamilton, Christopher P Ingalls.   

Abstract

Recent studies suggest a link between exercise-induced rhabdomyolysis and mutations of the ryanodine receptor (RYR1) associated with malignant hyperthermia (MH). We hypothesized that MH-susceptible mice (RYR1Y522S/wt) would exhibit greater anterior crural muscle [tibialis anterior (TA) and extensor digitorum longus (EDL) muscles] damage and strength deficits following the performance of a single or repeated bouts of eccentric contractions compared with wild-type (WT) mice. After a single injury bout, RYR1Y522S/wt mice produced more isometric torque than WT mice immediately and 3 and 7 days postinjury. Moreover, EDL muscle isometric specific force deficits were fully recovered for RYR1Y522S/wt but not WT mice 14 days postinjury. The percentage of fibers in TA muscle exhibiting signs of muscle damage 7 and 14 days postinjury were at least three times less in RYR1Y522S/wt than in WT mice. Uninjured and injured EDL muscle from RYR1Y522S/wt mice also displayed greater S-glutathionylation of RYR1 than that from WT mice. During the weekly injury bouts, torque production by RYR1Y522S/wt mice was fully recovered before the third and fourth injury bouts, whereas torque was still reduced for WT mice. Three days after multiple injury bouts, there were approximately 50% fewer fibers exhibiting signs of muscle damage in RYR1Y522S/wt than in WT TA muscle. These findings indicate that the RYR1Y522S/wt mutation protects skeletal muscle from exercise-induced muscle injury and do not support a direct association between MH susceptibility and contraction-induced rhabdomyolysis when core temperature is maintained at lower physiological temperatures during exercise.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787086      PMCID: PMC2584836          DOI: 10.1152/japplphysiol.90926.2008

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  53 in total

Review 1.  Degradation of oxidized proteins by the 20S proteasome.

Authors:  K J Davies
Journal:  Biochimie       Date:  2001 Mar-Apr       Impact factor: 4.079

Review 2.  Malignant hyperthermia: advances in clinical management and diagnosis.

Authors:  P M Hopkins
Journal:  Br J Anaesth       Date:  2000-07       Impact factor: 9.166

Review 3.  Potential health-related benefits of resistance training.

Authors:  R A Winett; R N Carpinelli
Journal:  Prev Med       Date:  2001-11       Impact factor: 4.018

Review 4.  Excitation-contraction uncoupling: major role in contraction-induced muscle injury.

Authors:  G L Warren; C P Ingalls; D A Lowe; R B Armstrong
Journal:  Exerc Sport Sci Rev       Date:  2001-04       Impact factor: 6.230

5.  Is there a link between malignant hyperthermia and exertional heat illness?

Authors:  Sheila Muldoon; Patricia Deuster; Barbara Brandom; Rolf Bunger
Journal:  Exerc Sport Sci Rev       Date:  2004-10       Impact factor: 6.230

6.  FK506 suppressed the inflammatory change of EAM in SJL/J mice.

Authors:  H Nemoto; K Nemoto; H Sugimoto; M Kinoshita
Journal:  J Neurol Sci       Date:  2001-12-15       Impact factor: 3.181

7.  Exercise-induced rhabdomyolysis: even the fit may suffer.

Authors:  N Sharma; H Winpenny; T Heymann
Journal:  Int J Clin Pract       Date:  1999-09       Impact factor: 2.503

8.  Multiple interacting gene products may influence susceptibility to malignant hyperthermia.

Authors:  R L Robinson; J L Curran; F R Ellis; P J Halsall; W J Hall; P M Hopkins; D E Iles; S P West; M A Shaw
Journal:  Ann Hum Genet       Date:  2000-07       Impact factor: 1.670

9.  Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis.

Authors:  F Wappler; M Fiege; M Steinfath; K Agarwal; J Scholz; S Singh; J Matschke; J Schulte Am Esch
Journal:  Anesthesiology       Date:  2001-01       Impact factor: 7.892

10.  B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators.

Authors:  T Girard; D Cavagna; E Padovan; G Spagnoli; A Urwyler; F Zorzato; S Treves
Journal:  J Biol Chem       Date:  2001-10-22       Impact factor: 5.157

View more
  13 in total

1.  Further development of a tissue engineered muscle repair construct in vitro for enhanced functional recovery following implantation in vivo in a murine model of volumetric muscle loss injury.

Authors:  Benjamin T Corona; Masood A Machingal; Tracy Criswell; Manasi Vadhavkar; Ashley C Dannahower; Christopher Bergman; Weixin Zhao; George J Christ
Journal:  Tissue Eng Part A       Date:  2012-05-10       Impact factor: 3.845

2.  Oxidative capacity and fatigability in run-trained malignant hyperthermia-susceptible mice.

Authors:  Clement Rouviere; Benjamin T Corona; Christopher P Ingalls
Journal:  Muscle Nerve       Date:  2012-04       Impact factor: 3.217

3.  Effect of prior exercise on thermal sensitivity of malignant hyperthermia-susceptible muscle.

Authors:  Benjamin T Corona; Susan L Hamilton; Christopher P Ingalls
Journal:  Muscle Nerve       Date:  2010-08       Impact factor: 3.217

4.  A tissue-engineered muscle repair construct for functional restoration of an irrecoverable muscle injury in a murine model.

Authors:  Masood A Machingal; Benjamin T Corona; Thomas J Walters; Venu Kesireddy; Christine N Koval; Ashley Dannahower; Weixin Zhao; James J Yoo; George J Christ
Journal:  Tissue Eng Part A       Date:  2011-07-28       Impact factor: 3.845

Review 5.  The role of junctophilin proteins in cellular function.

Authors:  Stephan E Lehnart; Xander H T Wehrens
Journal:  Physiol Rev       Date:  2022-01-10       Impact factor: 37.312

Review 6.  Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept.

Authors:  Sheila Riazi; Natalia Kraeva; Philip M Hopkins
Journal:  Anesthesiology       Date:  2018-01       Impact factor: 7.892

7.  Oestradiol affects skeletal muscle mass, strength and satellite cells following repeated injuries.

Authors:  Alexie A Larson; Cory W Baumann; Michael Kyba; Dawn A Lowe
Journal:  Exp Physiol       Date:  2020-09-08       Impact factor: 2.969

8.  Implantation of in vitro tissue engineered muscle repair constructs and bladder acellular matrices partially restore in vivo skeletal muscle function in a rat model of volumetric muscle loss injury.

Authors:  Benjamin T Corona; Catherine L Ward; Hannah B Baker; Thomas J Walters; George J Christ
Journal:  Tissue Eng Part A       Date:  2013-12-19       Impact factor: 3.845

9.  Eccentric contractions disrupt FKBP12 content in mouse skeletal muscle.

Authors:  Cory W Baumann; Russell G Rogers; Nidhi Gahlot; Christopher P Ingalls
Journal:  Physiol Rep       Date:  2014-07-16

Review 10.  Minimal Evidence for a Secondary Loss of Strength After an Acute Muscle Injury: A Systematic Review and Meta-Analysis.

Authors:  Gordon L Warren; Jarrod A Call; Amy K Farthing; Bemene Baadom-Piaro
Journal:  Sports Med       Date:  2017-01       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.